Live from the NIH registry
Studies recruiting near Murfreesboro right now
Top 25 of 80 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Vanderbilt-Ingram Cancer Center at Franklin — Franklin, Tennessee (26.1 mi)
· Sponsor: NRG Oncology
Galleri® in the Medicare Population.
Cancer
N/A
Interventional 50,000 participants sought
HCA Healthcare Brentwood — Brentwood, Tennessee (24.3 mi)
· Sponsor: GRAIL, Inc.
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
Psychiatric Consultants, Pc — Franklin, Tennessee (26.1 mi)
· Sponsor: Bristol-Myers Squibb
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
Lichen Planopilaris
Phase 2, Phase 3
Interventional 342 participants sought
Clinical Trial Site — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Priovant Therapeutics, Inc.
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Vanderbilt-Ingram Cancer Center Cool Springs — Franklin, Tennessee (26.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Radiographic Axial Spondyloarthritis
Phase 2
Interventional 315 participants sought
AARA Clinical Research - Murfreesboro Medical Clinic ( Site 0029) — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Obesity or Overweight, Diabetes Mellitus, Type 2
Phase 3
Interventional 1,500 participants sought
Research Site — Franklin, Tennessee (26.1 mi)
· Sponsor: AstraZeneca
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
Vanderbilt-Ingram Cancer Center Cool Springs — Franklin, Tennessee (26.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Obesity or Overweight, Weight-Related Comorbidity
Phase 3
Interventional 500 participants sought
Research Site — Franklin, Tennessee (26.1 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 1,500 participants sought
International Clinical Research - Tennessee LLC /ID# 259552 — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: AbbVie
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Hermitage, Tennessee (26.7 mi)
· Sponsor: Akero Therapeutics, Inc
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
Clinical Trials Center of Middle Tennessee, LLC — Franklin, Tennessee (26.1 mi)
· Sponsor: United Therapeutics
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Tennessee Oncology Proton Center — Franklin, Tennessee (26.1 mi)
· Sponsor: Proton Collaborative Group
Endometrial Cancer Vaginal Fluid Specimen Collection Study
Abnormal Uterine Bleeding (AUB), Endometrial Cancer
N/A
Observational 4,200 participants sought
Murfreesboro Medical Clinic — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Exact Sciences Corporation
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Phase 1
Interventional 246 participants sought
HCA Research Institute, LLC — Brentwood, Tennessee (24.3 mi)
· Sponsor: Shanghai Henlius Biotech
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD)
Phase 2
Interventional 315 participants sought
Psychiatric Consultants - Franklin /ID# 275133 — Franklin, Tennessee (26.1 mi)
· Sponsor: AbbVie
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 410 participants sought
Local Institution - 1038 — Franklin, Tennessee (26.1 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 675 participants sought
International Clinical Research - Tennessee /ID# 268548 — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: AbbVie
Study of ACR-2316 in Specific Advanced Solid Tumors
Specific Advanced Solid Tumors
Phase 1, Phase 2
Interventional 100 participants sought
Tennessee Oncology — Franklin, Tennessee (26.1 mi)
· Sponsor: Acrivon Therapeutics
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Sjögren's Syndrome
Phase 3
Interventional 844 participants sought
Murfreesboro Medical Clinic Westlawn — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Amgen
Vanderbilt Integrated Community TMS for Opioid Recovery
Opiod Use Disorder
N/A
Interventional 100 participants sought
Synaptic Psych — Brentwood, Tennessee (24.3 mi)
· Sponsor: Vanderbilt University Medical Center
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
International Clinical Research Tennessee Llc — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Incyte Corporation
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Phase 2
Interventional 284 participants sought
Clinical Trials Center of Middle Tennessee — Franklin, Tennessee (26.1 mi)
· Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Obesity and Overweight
Phase 3
Interventional 3,501 participants sought
Civia Health Nashville — La Vergne, Tennessee (14.9 mi)
· Sponsor: Pfizer
Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA)
Acne Vulgaris
Phase 3
Interventional 800 participants sought
Sagimet Investigative Site — Murfreesboro, Tennessee (1.2 mi)
· Sponsor: Sagimet Biosciences Inc.